Research in this program is focused on the basic mechanisms by which the host mobilizes and modulates cellular inflammatory reactions in defense against foreign antigens and infectious agents. In a multi-disciplinary approach, mechanisms of integrin adhesion, chemotaxis, signaling, mediator synthesis and apoptosis are explored in vitro and extended into experimental animal models (bacterial induced rodent arthritis; knockout and transgenic mice) for in vivo analysis. In addition, human conditions of chronic inflammatory disease in response to foreign implants, infectious pathogens, or of unknown etiology are explored at the cellular, molecular and biochemical levels. Understanding the mechanisms which control normal immune cell recruitment, activation and/or deletion and the switch to pathogenesis underlies the development of strategies for modulating chronic pathogenic inflammatory diseases. In an experimental model of arthritis, we have characterized the immunopathology through phenotypic, functional and morphologic parameters, in addition to DNA microarrays and ribonuclease protection assays, to identify targets for therapeutic intervention including leukocyte adhesion, signal transduction, cytokines, proteases, and nitric oxide. We recently demonstrated that human chorionic gonadotropin, a hormone that increases in pregnancy and declines sharply thereafter, was an effective inhibitor of experimental arthritis. Systemic delivery of hCG inhibited cytokines and NO, but increased immunosuppressive TGF-beta. These findings demonstrate unique immunoregulatory properties of hCG and provide insight into a potential mechanism whereby remission of RA symptoms occurs during pregnancy. In related studies, new insights into the regulation of immune function through TGF-beta, including TGF-beta-mediated apoptotic pathways in T lymphocytes, raise the prospect of novel approaches to controlling immunological tolerance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000046-29
Application #
6431997
Study Section
(OIIB)
Project Start
Project End
Budget Start
Budget End
Support Year
29
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Greenwell-Wild, Teresa; Vazquez, Nancy; Jin, Wenwen et al. (2009) Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114:1864-74
Nares, Salvador; Moutsopoulos, Niki M; Angelov, Nikola et al. (2009) Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis. Am J Pathol 174:1400-14
Mavragani, Clio P; Niewold, Timothy B; Moutsopoulos, Niki M et al. (2007) Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 56:3995-4004
Warburton, Gary; Nikitakis, Nikolaos G; Roberson, Patrick et al. (2007) Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 65:475-84
Katsifis, Gikas E; Moutsopoulos, Niki M; Wahl, Sharon M (2007) T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 32:252-64
Peng, Gang; Greenwell-Wild, Teresa; Nares, Salvador et al. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110:393-400
Wahl, Sharon M (2007) Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 19:55-62
Moutsopoulos, Niki M; Nares, Salvador; Nikitakis, Nikolaos et al. (2007) Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission. Am J Pathol 171:571-9
Wang, Xiao-Min; Wu, Tian-Xia; Hamza, May et al. (2007) Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 128:136-47
Skaleric, Uros; Gaspirc, Boris; McCartney-Francis, Nancy et al. (2006) Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease. Infect Immun 74:7010-3

Showing the most recent 10 out of 46 publications